The Cooper Companies, Inc. (coo)

Unlock full data in Terminal →

COO — Company Overview

The Cooper Companies, Inc. (COO) is a large-cap company in the Healthcare sector, operating in Medical Instruments & Supplies.

Ticker	COO
Sector	Healthcare
Industry	Medical Instruments & Supplies
Exchange	NMS
Market cap	$10.66B
Last price	$56.07
Size category	Large Cap

COO — Business Description

The Cooper Companies, Inc. (COO) operates in Medical Instruments & Supplies within the broader Healthcare market. The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services,…

Official website: https://www.coopercos.com.

COO — Investment Thesis

The investment thesis for The Cooper Companies, Inc. (COO) rests on how Healthcare dynamics, profitability, and valuation interact at today's price.

Revenue is expanding at roughly 0.6% year-over-year (public data).
Trailing P/E of 19.01× sits in a moderate band relative to high-growth peers.
Forward P/E (11.95×) is below trailing P/E — earnings may be expected to improve.
Equity market capitalization is approximately $10.66B.

See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.

COO — Financial Health

Financial health for The Cooper Companies, Inc. (COO) is summarized from publicly reported profitability, leverage, and cash-flow metrics.

Profit margin near 13.5% leaves a narrower cushion versus higher-margin peers. Positive free cash flow of $542.65M supports balance-sheet flexibility.

Trailing P/E	19.01×
Forward P/E	11.95×
Price / Sales	2.52×
Price / Book	1.28×
Gross margin	65.9%
Operating margin	20.8%
Profit margin	13.5%
Return on equity	6.8%
Debt / Equity	33.63
Free cash flow	$542.65M

COO — Growth Outlook

Growth outlook for The Cooper Companies, Inc. (COO) depends on demand trends in Medical Instruments & Supplies and the company's ability to convert revenue into sustainable earnings.

Revenue growth of 0.6% suggests steady but measured expansion.
Earnings growth of 3.6% year-over-year supports improving profitability.
Price is 37.6% below the 52-week high.
Shares trade 9.9% above the 52-week low — limited rebound so far.

COO — Competitive Position

The Cooper Companies, Inc. (COO) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.

Competes within Healthcare, specifically in Medical Instruments & Supplies.
Market capitalization of $10.66B places COO among large-cap peers.
Gross margin near 65.9% may reflect pricing power or favorable mix.

COO — Strengths

Strengths for The Cooper Companies, Inc. (COO) inferred from public financial metrics:

Earnings growth of 3.6% year-over-year.
Gross margin of 65.9% supports competitive unit economics.
Positive free cash flow ($542.65M).
Moderate leverage (debt/equity 33.63).
Large Cap scale ($10.66B) may provide distribution and funding advantages.

COO — Weaknesses

Weaknesses and pressure points for The Cooper Companies, Inc. (COO) based on available data:

Price 38% below the 52-week high — sustained negative sentiment.

COO — Opportunities

Trading 9.9% above the 52-week low — potential recovery if fundamentals stabilize.
Positive free cash flow enables reinvestment, debt reduction, or shareholder returns.
Forward earnings multiple below trailing P/E — potential earnings acceleration ahead.

COO — Risks

Standard market, regulatory, competitive, and execution risks apply to all public equities.

COO — Summary

The Cooper Companies, Inc. (COO) is a large-cap Healthcare company focused on Medical Instruments & Supplies, listed on NMS. Last price $56.07 with market cap $10.66B. Trailing P/E 19.01×. Revenue grew 0.6% year-over-year per public data. Notable strengths include earnings growth of 3.6% year-over-year. Key watch items include price 38% below the 52-week high — sustained negative sentiment. Public estimates and earnings snapshots for The Cooper Companies, Inc. are on this site; ownership, live news, and deeper models remain in Vest Terminal.

Start Free — open COO in Vest Terminal

Access live data, filings, ownership, and analysis for The Cooper Companies, Inc..

Create free account See plans

The Cooper Companies, Inc. FAQ

What does The Cooper Companies, Inc. (COO) do?

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that addre…

What is COO's P/E ratio?

The Cooper Companies, Inc. has a trailing P/E of 19.01× based on publicly available market data.

Does COO pay a dividend?

Indicated dividend yield: none reported. Confirm ex-dates and payout history in Vest Terminal.

What sector is COO in?

The Cooper Companies, Inc. is classified in Healthcare (Medical Instruments & Supplies) on NMS.

What is COO's market capitalization?

Approximate market cap: $10.66B.

What are the main risks for COO?

Standard market, competitive, and execution risks apply; see the Risks section.

What are the strengths of COO?

Potential positives include earnings growth of 3.6% year-over-year, gross margin of 65.9% supports competitive unit economics.

Where can I get analyst estimates for COO?

Public analyst price targets and consensus for The Cooper Companies, Inc. are on the free /stocks/coo/estimates page. Deeper estimate history and models are available in Vest Terminal.